Corporate Board Profile
Tech Score: 25/100
1 mention(s) identify JOSEPH LOSCALZO as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| IONIS PHARMACEUTICALS INC | 2022-04-20 | Dr. Loscalzo received his A.B. degree, summa cum laude, his Ph.D. in biochemistry, and his M.D. from the University of Pennsylvania... He is also a co-founder and member of the Scientific Advisory Board of Scipher Medicine, a private network medicine-based company matching patients with their most effective therapy... The Board believes Dr. Loscalzo is uniquely suited to serve on the Board and as our Chairman primarily because of his extensive scientific expertise. | Dr. Loscalzo holds a Ph.D. in biochemistry and M.D., has extensive scientific research experience, and is a co-founder and scientific advisor of a network medicine-based company, indicating strong technical and scientific expertise that likely includes programming or related skills. |
| Filing Date | Source Excerpt |
|---|---|
| 2018-04-11 | Dr. Loscalzo is Hersey Professor of the Theory and Practice of Medicine at Harvard Medical School, Chairman of the Department of Medicine, and Physician-in-Chief at Brigham and Women’s Hospital... He received his Ph.D. in biochemistry and M.D. from the University of Pennsylvania. |
| 2019-04-26 | Dr. Loscalzo is Hersey Professor of the Theory and Practice of Medicine at Harvard Medical School, Chairman of the Department of Medicine, and Physician-in-Chief at Brigham and Women’s Hospital. Dr. Loscalzo received his A.B. degree, summa cum laude, his Ph.D. in biochemistry, and his M.D. from the University of Pennsylvania. |
| 2022-04-20 | Dr. Loscalzo received his A.B. degree, summa cum laude, his Ph.D. in biochemistry, and his M.D. from the University of Pennsylvania... He is also a co-founder and member of the Scientific Advisory Board of Scipher Medicine, a private network medicine-based company matching patients with their most effective therapy... The Board believes Dr. Loscalzo is uniquely suited to serve on the Board and as our Chairman primarily because of his extensive scientific expertise. |
| 2024-04-25 | Dr. Loscalzo is uniquely suited to serve on the Board and as our Chairman primarily because of his extensive scientific expertise, including 32 years of research in the areas of vascular biology, thrombosis, and atherosclerosis. |
Data sourced from SEC filings. Last updated: 2025-08-30